The molecular mechanisms underpinning CCND1 dysregulation in these cancers appear to be similar to those observed in breast cancer, suggesting that circFOXK2 may serve as a central modulator of CCND1 expression across various malignancies. Here, CCND1 is linked to breast cancer.